NORTH BETHESDA, Md., Sept. 7, 2023 /PRNewswire-PRWeb/ — The International Society for Pharmaceutical Engineering (ISPE) is pleased to announce the results of our 2023–2024 International Board of Directors election. The election was run by an independent third party, Intelliscan, Inc., which provided ISPE with the final audited results.
The Board is responsible for the governance and strategic direction of the Society and will assume their elected positions at the 2023 ISPE Annual Meeting & Expo, taking place in Las Vegas, NV, USA, and virtually from 15–18 October. The following pharmaceutical industry leaders have been elected to positions on the 2023–2024 ISPE International Board of Directors.
Officers:
- Chair: Scott W. Billman, Vice President, Engineering, Pharmaceutical Services, Thermo Fisher Scientific
- Vice Chair: Jeffrey A. Biskup, PE, Executive Board Chairman/Co-Founder, CRB
- Treasurer: Vivianne J. Arencibia, Vice President, Global Quality Systems and Compliance, Moderna
- Secretary: Ylva Ek, Founder, Robur Life Science Advisory AB
- Past Chair: Michael L. Rutherford, Executive Director, Computer Systems Quality & Data Integrity, Syneos Health
- Ex Officio Non-voting Member: Thomas B. Hartman, President and CEO, ISPE
Directors Elected to a Second Term:
- Sarah C. Pope Miksinski, PhD, Executive Director, CMC Regulatory Affairs, Gilead Sciences
- Georg Singewald, PhD, Senior Vice President, Global Head of Engineering, Technology & Sustainability, Roche / Genentech
- Timothy J.N. Watson, PhD, Vice President – Head of CMC Regulatory Affairs, Gilead Sciences
New Director:
- Liz M. Dooley, MSc, Senior Director Global Engineering & Technology, Johnson & Johnson
Continuing Board Members:
The following Directors were elected in 2022 to serve a two-year term and will continue their service on the Board.
- Nina S. Cauchon, PhD, Director Regulatory Affairs – CMC, Amgen Inc.
- David Churchward, Global Head Sterility Assurance, Cell and Gene Technologies, Lonza Biologics
- Norman A. Goldschmidt, President, Genesis AEC
- Michael Martin, CEO, CAI
- Teresa Minero, Founder & CEO, LifeBee – Digitalizing Life Sciences
- Hirofumi Suzuki, PhD, Product Supply Japan, Head of Product Supply Coordination, Bayer Yakuhin Ltd.
Emerging Leader Representative, Ex Officio:
- Monique L. Sprueill, PMP, Director, GCP Quality Lead, Bristol Myers Squibb
Board Members Completing Service:
The following individuals will complete their Board service and end their term at the 2023 ISPE Annual Meeting & Expo. ISPE thanks these individuals for their dedication and commitment to the organization.
- Jörg Zimmermann, Vice President Vetter Development Service External Affairs, Vetter Pharma Fertigung GmbH & Co KG
- Zen-Zen Yen, Head of Engineering, Bayer AG
Visit ISPE Board of Directors Election Results and delve into comprehensive biographies of all the esteemed members of the ISPE’s International Board of Directors.
About ISPE
The International Society for Pharmaceutical Engineering (ISPE) is a global nonprofit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. The 20,000+ members of ISPE provide solutions to complex pharmaceutical industry challenges through innovation, member and workforce development, and technical, regulatory, and compliance collaborations in more than 120 countries worldwide. Founded in 1980, ISPE has its worldwide headquarters and training center in North Bethesda, Maryland, USA, and its operations center in Tampa, Florida, USA. For more information, visit ISPE.org.
Media Contact
Brad Ettinger, VP Marketing & Communications, ISPE, 3013649203, [email protected], www.ispe.org
SOURCE ISPE
